CTLA4 and exanthem: For chemotherapy alone, PD-1 or PD-L1 together with CTLA-4 (Group I) [47, 94], or together with chemotherapy on this basis (Group J) [93, 95], would significantly increase the risk of developing rash (Figures 5(f) and 5(g)).